Annual EBIT:
-$279.00M+$20.00M(+6.69%)Summary
- As of today, RCUS annual earnings before interest & taxes is -$279.00 million, with the most recent change of +$20.00 million (+6.69%) on December 31, 2024.
- During the last 3 years, RCUS annual EBIT has fallen by -$334.00 million (-607.27%).
- RCUS annual EBIT is now -607.27% below its all-time high of $55.00 million, reached on December 31, 2021.
Performance
RCUS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$142.00M-$134.00M(-1675.00%)Summary
- As of today, RCUS quarterly earnings before interest & taxes is -$142.00 million, with the most recent change of -$134.00 million (-1675.00%) on September 30, 2025.
- Over the past year, RCUS quarterly EBIT has dropped by -$37.00 million (-35.24%).
- RCUS quarterly EBIT is now -150.49% below its all-time high of $281.27 million, reached on December 31, 2021.
Performance
RCUS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$375.00M-$37.00M(-10.95%)Summary
- As of today, RCUS TTM earnings before interest & taxes is -$375.00 million, with the most recent change of -$37.00 million (-10.95%) on September 30, 2025.
- Over the past year, RCUS TTM EBIT has dropped by -$77.00 million (-25.84%).
- RCUS TTM EBIT is now -595.32% below its all-time high of $75.71 million, reached on September 30, 2022.
Performance
RCUS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
RCUS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +6.7% | -35.2% | -25.8% |
| 3Y3 Years | -607.3% | -104.6% | -595.3% |
| 5Y5 Years | -229.4% | -9249.5% | -317.8% |
RCUS EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -607.3% | +6.7% | -3650.0% | at low | -595.3% | +14.0% |
| 5Y | 5-Year | -607.3% | +6.7% | -150.5% | at low | -595.3% | +14.0% |
| All-Time | All-Time | -607.3% | +6.7% | -150.5% | at low | -595.3% | +14.0% |
RCUS EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$142.00M(-1675.0%) | -$375.00M(-10.9%) |
| Jun 2025 | - | -$8.00M(+93.4%) | -$338.00M(+22.5%) |
| Mar 2025 | - | -$122.00M(-18.4%) | -$436.00M(-40.6%) |
| Dec 2024 | -$279.00M(+6.7%) | -$103.00M(+1.9%) | -$310.00M(-4.0%) |
| Sep 2024 | - | -$105.00M(+0.9%) | -$298.00M(-9.2%) |
| Jun 2024 | - | -$106.00M(-2750.0%) | -$273.00M(-9.2%) |
| Mar 2024 | - | $4.00M(+104.4%) | -$250.00M(+26.5%) |
| Dec 2023 | -$299.00M(-13.3%) | -$91.00M(-13.8%) | -$340.00M(-5.1%) |
| Sep 2023 | - | -$80.00M(+3.6%) | -$323.44M(-3.4%) |
| Jun 2023 | - | -$83.00M(+3.5%) | -$312.84M(-4.7%) |
| Mar 2023 | - | -$86.00M(-15.5%) | -$298.82M(-6.7%) |
| Dec 2022 | -$264.00M(-580.0%) | -$74.44M(-7.3%) | -$280.00M(-469.8%) |
| Sep 2022 | - | -$69.40M(-0.6%) | $75.71M(+13.0%) |
| Jun 2022 | - | -$68.98M(-2.7%) | $66.97M(+12.0%) |
| Mar 2022 | - | -$67.18M(-123.9%) | $59.81M(+10.3%) |
| Dec 2021 | $55.00M | $281.27M(+460.0%) | $54.25M(+119.4%) |
| Sep 2021 | - | -$78.14M(-2.6%) | -$279.03M(-40.0%) |
| Jun 2021 | - | -$76.14M(-4.7%) | -$199.34M(-18.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$72.75M(-39.9%) | -$168.58M(-35.7%) |
| Dec 2020 | -$123.00M(-45.2%) | -$52.01M(-3451.3%) | -$124.23M(-38.4%) |
| Sep 2020 | - | $1.55M(+103.4%) | -$89.75M(+21.7%) |
| Jun 2020 | - | -$45.38M(-59.8%) | -$114.55M(-16.5%) |
| Mar 2020 | - | -$28.40M(-62.0%) | -$98.34M(-10.9%) |
| Dec 2019 | -$84.71M(-54.4%) | -$17.53M(+24.6%) | -$88.71M(-4.8%) |
| Sep 2019 | - | -$23.25M(+20.3%) | -$84.67M(-15.1%) |
| Jun 2019 | - | -$29.16M(-55.3%) | -$73.56M(-22.0%) |
| Mar 2019 | - | -$18.77M(-39.2%) | -$60.30M(-9.9%) |
| Dec 2018 | -$54.86M(-2.7%) | -$13.48M(-11.0%) | -$54.86M(-0.3%) |
| Sep 2018 | - | -$12.14M(+23.6%) | -$54.72M(+16.7%) |
| Jun 2018 | - | -$15.90M(-19.3%) | -$65.71M(-10.5%) |
| Mar 2018 | - | -$13.33M(+0.1%) | -$59.47M(-11.3%) |
| Dec 2017 | -$53.44M(-193.9%) | -$13.34M(+42.3%) | -$53.44M(-33.3%) |
| Sep 2017 | - | -$23.13M(-139.4%) | -$40.10M(-136.4%) |
| Jun 2017 | - | -$9.66M(-32.4%) | -$16.96M(-132.4%) |
| Mar 2017 | - | -$7.30M | -$7.30M |
| Dec 2016 | -$18.18M | - | - |
FAQ
- What is Arcus Biosciences, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Arcus Biosciences, Inc.?
- What is Arcus Biosciences, Inc. annual EBIT year-on-year change?
- What is Arcus Biosciences, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Arcus Biosciences, Inc.?
- What is Arcus Biosciences, Inc. quarterly EBIT year-on-year change?
- What is Arcus Biosciences, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Arcus Biosciences, Inc.?
- What is Arcus Biosciences, Inc. TTM EBIT year-on-year change?
What is Arcus Biosciences, Inc. annual earnings before interest & taxes?
The current annual EBIT of RCUS is -$279.00M
What is the all-time high annual EBIT for Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. all-time high annual earnings before interest & taxes is $55.00M
What is Arcus Biosciences, Inc. annual EBIT year-on-year change?
Over the past year, RCUS annual earnings before interest & taxes has changed by +$20.00M (+6.69%)
What is Arcus Biosciences, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of RCUS is -$142.00M
What is the all-time high quarterly EBIT for Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. all-time high quarterly earnings before interest & taxes is $281.27M
What is Arcus Biosciences, Inc. quarterly EBIT year-on-year change?
Over the past year, RCUS quarterly earnings before interest & taxes has changed by -$37.00M (-35.24%)
What is Arcus Biosciences, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of RCUS is -$375.00M
What is the all-time high TTM EBIT for Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. all-time high TTM earnings before interest & taxes is $75.71M
What is Arcus Biosciences, Inc. TTM EBIT year-on-year change?
Over the past year, RCUS TTM earnings before interest & taxes has changed by -$77.00M (-25.84%)